Abstract P138 – Table 1. Baseline demographic and laboratory characteristics of the study patients
Characteristics | Raltegravir | Elvitegravir | Dolutegravir | p value |
---|---|---|---|---|
Patient, n | 28 | 29 | 32 | 0.3675 |
Gender (F), n (%) | 26 (93) | 26 (90) | 27 (84) | 0.3549 |
Age, median years (range) | 41 (19 to 80) | 41 (22 to 73) | 42 (21 to 65) | 0.9391 |
Baseline CD4 + T‐cell count, median (range) | 417 (12 to 1215) | 353 (9 to 1218) | 376 (8 to 819) | 0.6331 |
Baseline CD4/CD8 ratio, median (range) | 0.42 (0.01 to 1.33) | 0.44 (0.01 to 1.5) | 0.44 (0.03 to 1.15) | 0.9513 |
Baseline HIV‐1 RNA load, median copies/mL (range) | 2.5 + E5 (5 + E3‐2.4 E6) | 3.3 + E5 (1.4 + E3‐6.6 + E6) | 7.9 + E5 (6.5 + E3‐7.8 + E6) | 0.2669 |